CARLISLE COMPANIES INCORPORATED
At today's price, CARLISLE COMPANIES INCORPORATED (CSL) is priced for +7.7% growth. boothcheck doesn't publish a fair value or a price target; it shows what the price assumes, so you can judge whether that bar is too high. Built from SEC EDGAR filings.
At $361, the price pays about 17x company-wide operating income, which works out to roughly 11% annual operating-profit growth held for five years. That pace is within what Carlisle has recently delivered; the bet is on how long it persists, not the rate. The business throws off real cash at a 20% operating margin, and the X-ray splits cleanly: relative-multiple and growth-DCF methods land at or above today's price, while asset-based and earnings-power methods sit below it. The same company loo
Is CSL overvalued? See what's priced in →
754 institutional managers reported holding CSL in 13F filings for the quarter ended 2026-03-31. 83 opened new positions that quarter. Held by BlackRock, Vanguard Group, Morgan Stanley, among others. On the short side, 2.6M shares were sold short as of the 2026-06-15 count, about 6% of shares outstanding (8.2 days of typical volume to cover).
Quarterly 13F filings arrive up to 45 days after quarter end, so the picture is never current (filed through 2026-05-29). Nothing here is investment advice.
CSL has cut its share count 22% over the past five years, spending $4.51B on repurchases. It pays a dividend, and has paid one every year in our records (17 and counting), raised 15 years straight; the current rate is $4.20 a share annually. Cash returned over the past three years: $482.30M in dividends and $3.81B in repurchases.
Share counts are split-adjusted; repurchase totals are gross of share issuance. Nothing here is investment advice.
No open-market insider buys on file at CSL over the trailing three years. Absence is a fact about the company, not a signal. 22 officers and directors are on file.
Code P open-market purchases from SEC Form 4 filings, non-derivative, excluding scheduled 10b5-1 plans. Nothing here is investment advice.
CSL's recent reports: the day-one move, then what the following quarter actually did.
| report | day one | next quarter |
|---|---|---|
| 2023-04-29 | +1.5% | +18.9% |
| 2023-07-28 | +3.0% | -6.5% |
| 2023-10-28 | +4.9% | +25.6% |
| 2024-04-27 | +6.7% | +1.2% |
Day-one is the close-to-close move around the filing. Nothing here is investment advice.
CSL's latest 8-K filings: 2026-04-30 (items 5.02, 5.07, 9.01); 2026-04-23 (items 2.02, 9.01); 2026-02-03 (items 2.02, 9.01); 2025-11-03 (items 5.02, 7.01, 9.01); 2025-10-29 (items 2.02, 9.01).
Item codes are the SEC's own classification of what each report discloses. Nothing here is investment advice.
Last analyzed: June 27, 2026
Each week boothcheck ranks the stocks whose prices are betting on the most. Read the most stretched bets archive →
boothcheck is also on Android. Get the app on Google Play →
For informational and research purposes only. Not investment advice. Not a recommendation to buy, sell, or hold any security. boothcheck is not a registered investment adviser. Past performance does not guarantee future results.